Oxidative Stress

Targeting NRF2/SIRT3: Calycosin Suppresses Podocyte Pyroptosis in Chronic Renal Failure.

The international journal of biochemistry & cell biology

Abstract

BACKGROUND: Calycosin (Cal) exhibits anti-inflammatory and antioxidant properties. Its function in controlling podocyte pyroptosis and the underlying mechanisms are still unknown, though. The purpose of this study was to examine whether Cal alleviates chronic renal failure (CRF) by modulating podocyte pyroptosis through the nuclear factor erythroid 2-related factor 2 (NRF2)/Sirtuin 3 (SIRT3) signaling pathway. METHODS: To assess Cal's effects in vivo, an adenine-induced CRF mouse model was created. Renal function was assessed by measuring serum blood urea nitrogen (BUN), creatinine (Cr), uric acid (UA), urinary protein levels and histopathological staining. In vitro, mouse podocytes (MPC5) were treated with lipopolysaccharide (LPS) to induce injury. Cell viability, inflammatory cytokines, pyroptosis-related proteins, and reactive oxygen species (ROS) levels were analyzed. NRF2 knockdown was performed to verify the underlying mechanism. RESULTS: Cal significantly improved renal function in CRF mice, as evidenced by decreased BUN, Cr, UA, and urinary protein levels. Cal alleviated glomerular injury and inflammatory infiltration. Cal also reduced interleukin-1β (IL-1β), interleukin-18 (IL-18), and tumor necrosis factor-α (TNF-α). In vitro, Cal restored podocyte viability and suppressed LPS-induced increases in IL-1β, IL-18, caspase-1, and gasdermin D (GSDMD). Cal also reduced ROS production and inhibited activation of NLR family pyrin domain containing 3 (NLRP3), while upregulating NRF2 and SIRT3. Notably, NRF2 knockdown abolished the protective effects of Cal. CONCLUSION: Cal alleviates CRF by inhibiting podocyte pyroptosis through activation of the NRF2/SIRT3 signaling pathway. This impact is linked to inhibition of NLRP3 inflammasome activation and diminished generation of ROS.

Key Findings

  • Calycosin significantly improved renal function in chronic renal failure (CRF) mice by reducing serum BUN, creatinine, uric acid, and urinary protein levels.
  • Calycosin suppressed podocyte pyroptosis by decreasing inflammatory cytokines IL-1β, IL-18, TNF-α, and pyroptosis-related proteins caspase-1 and gasdermin D in vitro.
  • Calycosin activated the NRF2/SIRT3 signaling pathway, which inhibited NLRP3 inflammasome activation and reduced reactive oxygen species (ROS) production; NRF2 knockdown abolished these protective effects.

Clinical Significance

Calycosin shows therapeutic potential for chronic renal failure by protecting podocytes from pyroptosis through modulation of oxidative stress and inflammation via the NRF2/SIRT3 pathway.

Citation

Yu Jiangen, Li Lin, Zhang Xiaoyunet al.. Targeting NRF2/SIRT3: Calycosin Suppresses Podocyte Pyroptosis in Chronic Renal Failure. The international journal of biochemistry & cell biology. 2026-Nov-15.

DOI: 10.1016/j.biocel.2026.107076